PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Research and Development Centre, GSK, Siena, Italy (S.P., K.V., R.R.); Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts (S.K.); IconOVir Bio, San Diego, California (Y.K.); and La Jolla Institute for Immunology, La Jolla, California (Y.K.).\', \'Research and Development Centre, GSK, Siena, Italy (S.P., K.V., R.R.); Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts (S.K.); IconOVir Bio, San Diego, California (Y.K.); and La Jolla Institute for Immunology, La Jolla, California (Y.K.) rino.r.rappuoli@gsk.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1124/pharmrev.120.000285
?:hasPublicationType
?:journal
  • Pharmacological reviews
is ?:pmid of
?:pmid
?:pmid
  • 35101964
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 9.472
?:rankingScore_hIndex
  • 205
is ?:relation_isRelatedTo_publication of
?:title
  • Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35101964>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35101964>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all